Page last updated: 2024-11-07

azauridine and Lymphoma, Non-Hodgkin

azauridine has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BUTTOO, AS1
ISRAUELS, MC1
WILKINSON, JF1

Other Studies

1 other study available for azauridine and Lymphoma, Non-Hodgkin

ArticleYear
HYPOCHOLESTEROLAEMIA AND OROTIC ACIDURIA DURING TREATMENT WITH 6-AZAURIDINE.
    British medical journal, 1965, Feb-27, Volume: 1, Issue:5434

    Topics: Antineoplastic Agents; Azauridine; Cholesterol; Drug Therapy; Leukemia; Leukocyte Count; Lymphoma; L

1965